跳至主要内容
临床试验/CTRI/2025/11/096835
CTRI/2025/11/096835尚未招募2/3 期

Role of Aragwadhadi lepa in vicharchika

Uttarakhand Ayurved University Dehradun1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年11月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Kandu(Itching)

研究概览

简要总结

Skin disease are a major health problem affecting a high proportion of the population. Vicharchika is correlated with eczema in modern science.Modern science has no specific medication for cure of eczema but symptomatic treatment like steriods are used which is not safe and also produce side effects.A whole world is looking toward Ayurveda for it.Aragwadhadi lepa is a a very cost effective drug for the patients and is accessible to the patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having sign and symptoms of Vicharchika as per subjective criteria Chronicity less than 5 year Age group between 20 to 60 year Patient willing to participate in above mentioned trial with informed consent.

排除标准

  • Age group less than 20 year and more than 60 year Patient with other cutaneous symptoms of Psoriasis Leprosy Local burn etc Any other secondary skin disease Chronicity more than 5 year Uncontrolled Diabetic.

结局指标

主要结局

Kandu(Itching)

时间窗: 6 weeks

Vedana(Pain)

时间窗: 6 weeks

Daha(Burning sensation)

时间窗: 6 weeks

Vivarnata(Discolouration)

时间窗: 6 weeks

Rukshta(Dryness)

时间窗: 6 weeks

次要结局

  • Number of lesion(Area occupied by the lesion)

研究者

发起方
Uttarakhand Ayurved University Dehradun
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Sanjay kumar Tripathi

Dr Sanjay kumar Tripathi

研究点 (1)

Loading locations...

相似试验